Premier Healthcare

Patient Portal






Accountable Care Organization (ACO)

Quality Performance Report 2015:

2015 Reporting Period
Measure Number Performance Measures ACO Performance Rate Mean performance rate (SSP-ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 77.65 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 94.10 92.65
ACO-3 CAHPS: Patients' Rating of Provider 93.31 91.94
ACO-4 CAHPS: Access to Specialists 83.71 83.61
ACO-5 CAHPS: Health Promotion and Education 51.92 59.06
ACO-6 CAHPS: Shared Decision Making 75.14 75.17
ACO-7 CAHPS: Health Status/Functional Status 73.31 72.30
ACO-34 CAHPS: Stewardship of Patient Resources* 24.07 26.87
ACO-8 Risk Standardized, All Condition Readmission 13.97 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission 16.18 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 48.03 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure* 72.24 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 53.51 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.07 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 0.68 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 100.00% 80.14%
ACO-39 Documentation of Current Medications in the Medical Record* 84.39% 84.07%
ACO-13 Falls: Screening for Future Fall Risk 55.48% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization 66.17% 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 51.63% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 52.85% 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 95.43% 90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 37.94% 45.25%
ACO-19 Colorectal Cancer Screening 69.50% 60.06%
ACO-20 Breast Cancer Screening 64.65% 65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 81.24% 70.04%
ACO-40 Depression Remission at Twelve Months* NA NA
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 13.46% 20.38%
ACO-41 Diabetes: Eye Exam* 33.06% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure 69.44% 69.62%
ACO-30 Ischemic Vascular Disease: use of Aspirin or Another Antithrombotic 83.03% 83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for left Ventricular Systolic Dysfunction (LVSD) 94.17% 87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 67.73% 77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = Left Ventricular Systolic Dysfunction, ACE = Angiotensin-Converting Enzyme, ARB = Angiotensin Receptor Blocker, CAD = Coronary Artery Disease.
*= Measure required beginning Reporting Year 2015.
N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A.